Posted in | News

Augmented Reality Imaging Supports Clinical Decision-Making for Vascular Neurosurgeons

Image Credits: Leica Microsystems GmbH

At the Congress of Neurological Surgeons (CNS) Annual Meeting 2017, Boston, USA, Leica Microsystems will showcase its new groundbreaking GLOW augmented reality (AR) platform featuring the latest innovation in vascular fluorescence imaging: GLOW800 AR fluorescence. Visitors to the booth will also be able to experience FL560 fluorescence, the first FDA 510(k) cleared microscope filter for vascular fluorescence with fluorescein and FL400 the first blue light fluorescence available as a FDA Class I device.

GLOW800 AR fluorescence allows neurosurgeons to observe both the naturally-colored cerebral anatomy and highlighted vascular blood flow in one single augmented, real-time view with full depth perception. The surgeon thus has a complete view of anatomy and physiology to support crucial decisions and actions during vascular neurosurgery.

For the past decade Leica Microsystems has been pioneering new fluorescence imaging technologies in partnership with surgeons to advance surgical practices. GLOW800 and future modalities based on the GLOW AR platform will allow surgeons to perform life-changing neurosurgical interventions with the confidence that they have the best possible visual information right in the field of view.

Markus Lusser, President, Leica Microsystems

Until now, viewing blood flow with Indocyanine Green (ICG) fluorescent agent meant pausing surgery to watch a separate near infrared (NIR) black and white video. The surgeon then needed to recall and reconcile this with the anatomical microscope view. GLOW800 AR overcomes this challenge by combining blood flow information into the natural image. It is the first of many imaging modalities that will be based on the GLOW AR platform.

Leica Microsystems is a company that works closely with neurosurgeons to bring new technologies to the market that really respond to our needs. GLOW800 AR is an exciting new approach which provides a totally new view during vascular neurosurgery. I have excellent spatial orientation and I am impressed with the crisp delineation of vessels. I believe GLOW800 AR fluorescence will have a significant impact on surgical outcomes in the future.

Cleopatra Charalampaki, Professor of Neurosurgery, Cologne Medical Center, Germany

The Congress of Neurological Surgeons (CNS) Annual Meeting 2017, takes place in Boston, USA from October 9 to October 11. Visitors to booth #211 will be among the first to view all of Leica’s surgical fluorescence solutions fully integrated into the M530 OH6 surgical microscope platform.

*GLOW800 is not yet cleared for use

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Leica Microsystems GmbH. (2017, October 09). Augmented Reality Imaging Supports Clinical Decision-Making for Vascular Neurosurgeons. AZoM. Retrieved on February 09, 2023 from https://www.azom.com/news.aspx?newsID=48257.

  • MLA

    Leica Microsystems GmbH. "Augmented Reality Imaging Supports Clinical Decision-Making for Vascular Neurosurgeons". AZoM. 09 February 2023. <https://www.azom.com/news.aspx?newsID=48257>.

  • Chicago

    Leica Microsystems GmbH. "Augmented Reality Imaging Supports Clinical Decision-Making for Vascular Neurosurgeons". AZoM. https://www.azom.com/news.aspx?newsID=48257. (accessed February 09, 2023).

  • Harvard

    Leica Microsystems GmbH. 2017. Augmented Reality Imaging Supports Clinical Decision-Making for Vascular Neurosurgeons. AZoM, viewed 09 February 2023, https://www.azom.com/news.aspx?newsID=48257.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit